About LivaNova
LivaNova (NASDAQ:LIVN) is a global medical technology company focused on developing innovative solutions that improve patient outcomes and enhance lives. The company operates two primary business segments: Cardiovascular and Neuromodulation. In the cardiovascular realm, LivaNova is dedicated to advancing technology for cardiac surgery, including heart valve therapy, and cardiopulmonary solutions. On the neuromodulation front, the company is a pioneer in offering devices designed to treat epilepsy and depression, aiming to address some of the most challenging areas of unmet medical needs. With a commitment to clinical excellence and innovation, LivaNova's projects and objectives are centered around transforming the standard of care for patients around the world, driving sustainable growth, and extending its reach into new markets to improve more lives with their medical technologies.
Snapshot
Operations
Produtos e/ou serviços de LivaNova
- Vagus Nerve Stimulation (VNS) Therapy Systems for drug-resistant epilepsy and treatment-resistant depression, offering a unique non-pharmacological treatment option.
- Perceval sutureless aortic valve, providing a less invasive option for surgical aortic valve replacement in patients with aortic valve disease.
- SenTiva generator and VNS Therapy Programming System, an advanced option for managing seizures in drug-resistant epilepsy, allowing for tailored treatment.
- LifeSPARC advanced circulatory support system, designed for rapid deployment in patients needing circulatory support during cardiac procedures or acute heart failure.
- Solox cardiovascular oxygenator, a key component in cardiopulmonary bypass surgery, supporting patients' lungs and heart during complex cardiac surgeries.
- Membrane oxygenators, which play a crucial role in extracorporeal membrane oxygenation (ECMO) for patients with life-threatening heart and lung conditions.
equipe executiva do LivaNova
- Mr. Vladimir A. MakatsariaCEO & Director
- Mr. Alex Shvartsburg C.M.A.Chief Financial Officer